| Autor: |
Li, Weihua, Wan, Rui, Guo, Lei, Chang, Geyun, Jiang, Dong, Meng, Lin, Ying, Jianming |
| Rok vydání: |
2022 |
| Předmět: |
|
| DOI: |
10.6084/m9.figshare.19738687.v1 |
| Popis: |
Additional file 1: Table S1. The gene panel used in RNA NGS. Table S2. Characteristics of NSCLC patients who underwent DNA NGS. Table S3. Clinicopathological features of NSCLC cases with exonic- or intronic/intergenic/mixed-breakpoint fusions. Table S4. Exonic-breakpoint fusions identified by DNA NGS in paired samples from the same patient. Table S5. The clinical outcomes of matched targeted therapy in NSCLC cases with exonic-breakpoint fusions. Table S6. Baseline characteristics of 67 NSCLC patients with RNA NGS/IHC-confirmed ALK fusions who received first-line crizotinib. Table S7. Clinical response to crizotinib treatment for NSCLC patients with intronic-breakpoint or exonic-breakpoint ALK fusions confirmed by RNA NGS/IHC. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
